Allianz Asset Management
FLGT icon

Allianz Asset Management’s Fulgent Genetics FLGT Stock Holding History

Allianz Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.17M Sell
154,577
-27,345
-15% -$464K ﹤0.01% 1588
2026
Q1 		$2.89M Buy
181,922
+48,448
+36% +$1.05M ﹤0.01% 1411
2025
Q4 		$3.51M Buy
133,474
+42,605
+47% +$1.11M ﹤0.01% 1313
2025
Q3 		$2.05M Buy
90,869
+49,485
+120% +$1.02M ﹤0.01% 1489
2025
Q2 		$823K Buy
+41,384
New +$807K ﹤0.01% 1717
2021
Q4 		– Sell
-3,187
Closed -$287K – 2592
2021
Q3 		$287K Sell
3,187
-4,207
-57% -$382K ﹤0.01% 2424
2021
Q2 		$682K Sell
7,394
-2,046
-22% -$163K ﹤0.01% 1901
2021
Q1 		$912K Buy
+9,440
New +$974K ﹤0.01% 1679
2020
Q2 		– Sell
-25,545
Closed -$275K – 2437
2020
Q1 		$275K Sell
25,545
-1,713
-6% -$23.9K ﹤0.01% 2235
2019
Q4 		$352K Buy
+27,258
New +$324K ﹤0.01% 2524

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allianz Asset Management's FLGT Position: Q2 2026 in Review

Allianz Asset Management reduced its Fulgent Genetics (FLGT) stake by 15% in Q2 2026, selling an estimated $464K and leaving 154,577 shares worth $3.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1588.

Allianz Asset Management first reported a position in FLGT in Q4 2019 and has held it in 10 quarters since. The position peaked at $3.51M in Q4 2025. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Allianz Asset Management held 154,577 shares of Fulgent Genetics worth $3.17M as of Q2 2026.
  • Allianz Asset Management sold 27,345 Fulgent Genetics shares in Q2 2026, an estimated $464K.
  • Fulgent Genetics made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1588 holding.
  • Allianz Asset Management first reported a position in Fulgent Genetics in Q4 2019 and has held it in 10 quarters since.
  • Allianz Asset Management's Fulgent Genetics position peaked at $3.51M in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.